1. Home
  2. TRML vs CRAI Comparison

TRML vs CRAI Comparison

Compare TRML & CRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRML
  • CRAI
  • Stock Information
  • Founded
  • TRML 2021
  • CRAI 1965
  • Country
  • TRML United States
  • CRAI United States
  • Employees
  • TRML N/A
  • CRAI N/A
  • Industry
  • TRML Biotechnology: Pharmaceutical Preparations
  • CRAI Other Consumer Services
  • Sector
  • TRML Health Care
  • CRAI Consumer Discretionary
  • Exchange
  • TRML Nasdaq
  • CRAI Nasdaq
  • Market Cap
  • TRML 1.2B
  • CRAI 1.4B
  • IPO Year
  • TRML N/A
  • CRAI 1998
  • Fundamental
  • Price
  • TRML $47.97
  • CRAI $187.46
  • Analyst Decision
  • TRML Hold
  • CRAI Buy
  • Analyst Count
  • TRML 12
  • CRAI 1
  • Target Price
  • TRML $47.04
  • CRAI $235.00
  • AVG Volume (30 Days)
  • TRML 657.3K
  • CRAI 115.9K
  • Earning Date
  • TRML 11-13-2025
  • CRAI 10-30-2025
  • Dividend Yield
  • TRML N/A
  • CRAI 1.04%
  • EPS Growth
  • TRML N/A
  • CRAI 44.21
  • EPS
  • TRML N/A
  • CRAI 8.27
  • Revenue
  • TRML N/A
  • CRAI $712,913,000.00
  • Revenue This Year
  • TRML N/A
  • CRAI $9.01
  • Revenue Next Year
  • TRML N/A
  • CRAI $4.26
  • P/E Ratio
  • TRML N/A
  • CRAI $22.73
  • Revenue Growth
  • TRML N/A
  • CRAI 9.28
  • 52 Week Low
  • TRML $11.56
  • CRAI $152.57
  • 52 Week High
  • TRML $48.27
  • CRAI $214.66
  • Technical
  • Relative Strength Index (RSI)
  • TRML 90.29
  • CRAI 47.31
  • Support Level
  • TRML $47.88
  • CRAI $180.01
  • Resistance Level
  • TRML $48.00
  • CRAI $187.04
  • Average True Range (ATR)
  • TRML 0.05
  • CRAI 5.00
  • MACD
  • TRML -0.84
  • CRAI 0.35
  • Stochastic Oscillator
  • TRML 83.78
  • CRAI 60.30

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

About CRAI CRA International Inc.

CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.

Share on Social Networks: